Search results
Order by most recent / most popular / relevance
Results: 1-10 of 35
Leave to appeal to the Court of Appeal Re: motion to strike pleadings granted in respect of claims to unjust enrichment, denied in respect of claims under the Trade-Marks Act
- Borden Ladner Gervais LLP
- -
- Canada
- -
- March 6 2013
In this case, Apotex has sued Eli Lilly for damages pursuant to s. 8 of the Patented Medicines (Notice of Compliance) Regulations. Eli Lilly brought a
Industry news
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 2 2012
Bill C-11, The Copyright Modernization Act has received Royal Assent
Other industry news
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 2 2012
As we mentioned last week, CIPO is consulting on practice respecting inventive concept, statutory subject matter, diagnostic methods and medical uses
Appeal dismissed regarding motion granting leave to amend pleadings
- Borden Ladner Gervais LLP
- -
- Canada
- -
- March 12 2012
The Federal Court of Appeal (FCA) upheld a decision of the Motions Judge, which upheld the decision of a Prothonotary, granting leave to the respondents to amend their pleadings
Production of product and manufacturing information denied
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 10 2011
This is an appeal of a decision of a Prothonotary, refusing to order Mylan to produce requested information about its manufacturing process and the crystal structure of efavirenz in its product
Other industry news of note
- Borden Ladner Gervais LLP
- -
- Canada
- -
- February 24 2011
Health Canada has posted information on How to Pay Fees and a Submission Fee Application Form
Minister’s decision to reject NDS at screening stage quashed
- Borden Ladner Gervais LLP
- -
- Canada
- -
- February 24 2011
In this case, the Hearings Judge dismissed Hospira’s application for judicial review of the Minister of Health’s decision to reject a New Drug Submission (NDS) without prejudice to the ability to refile
Other industry news of note
- Borden Ladner Gervais LLP
- -
- Canada
- -
- February 16 2011
Parliament has voted down Bill C-474 - An Act Respecting the Seeds Regulations (analysis of potential harm
Other industry news of note
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 26 2011
The Canadian Chamber of Commerce has recently released a report entitled: Innovation for a Better Tomorrow: Closing Canada's Intellectual Property Gap in the Pharmaceutical Sector
Bayer v. Minister of Health
- Borden Ladner Gervais LLP
- -
- Canada
- -
- June 28 2010
The Court of Appeal upheld the decision of the Federal Court, dismissing the application by Bayer for a review of the decision of the Minister of Health refusing to list a patent on the Patent Register in respect of its drug product
